Christopher Pleyer

516 total citations
19 papers, 280 citations indexed

About

Christopher Pleyer is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Christopher Pleyer has authored 19 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Christopher Pleyer's work include Chronic Lymphocytic Leukemia Research (11 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and CAR-T cell therapy research (4 papers). Christopher Pleyer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and CAR-T cell therapy research (4 papers). Christopher Pleyer collaborates with scholars based in United States, Netherlands and Australia. Christopher Pleyer's co-authors include Clare Sun, Adrian Wiestner, Fahad Saeed, Jan Flesche, Jennifer Lotter, Inhye E. Ahn, Xin Tian, Pia Nierman, Susan Soto and Jeanine Superata and has published in prestigious journals such as The Lancet, Blood and Leukemia.

In The Last Decade

Christopher Pleyer

17 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Pleyer United States 8 121 95 78 69 52 19 280
Marjolein L. Donker Netherlands 7 70 0.6× 55 0.6× 163 2.1× 23 0.3× 63 1.2× 9 409
Benedetto Neri Italy 9 24 0.2× 38 0.4× 41 0.5× 26 0.4× 16 0.3× 45 207
L. S. Zubarovskaya Russia 9 34 0.3× 62 0.7× 49 0.6× 23 0.3× 78 1.5× 140 297
Cristina Estany Spain 9 171 1.4× 250 2.6× 154 2.0× 373 5.4× 67 1.3× 11 515
Juan S. Lasa Argentina 7 18 0.1× 70 0.7× 66 0.8× 32 0.5× 21 0.4× 19 355
Sara Miqueleiz Italy 10 179 1.5× 41 0.4× 98 1.3× 147 2.1× 20 0.4× 17 272
Yasutaka Aoyama Japan 11 43 0.4× 80 0.8× 77 1.0× 44 0.6× 32 0.6× 43 294
E. L. Egan Ireland 10 72 0.6× 57 0.6× 65 0.8× 101 1.5× 10 0.2× 21 387
Young Bae Choi South Korea 11 41 0.3× 68 0.7× 35 0.4× 23 0.3× 28 0.5× 36 313
Connor Prosty Canada 11 26 0.2× 60 0.6× 52 0.7× 25 0.4× 44 0.8× 41 278

Countries citing papers authored by Christopher Pleyer

Since Specialization
Citations

This map shows the geographic impact of Christopher Pleyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Pleyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Pleyer more than expected).

Fields of papers citing papers by Christopher Pleyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Pleyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Pleyer. The network helps show where Christopher Pleyer may publish in the future.

Co-authorship network of co-authors of Christopher Pleyer

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Pleyer. A scholar is included among the top collaborators of Christopher Pleyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Pleyer. Christopher Pleyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brofferio, Alessandra, Jeanine Superata, Susan Soto, et al.. (2024). Cardiac Monitoring of Patients on Btki for Chronic Lymphocytic Leukemia. Blood. 144(Supplement 1). 6787–6787.
2.
Tian, Xin, et al.. (2023). Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL. Leukemia & lymphoma. 64(14). 2306–2315. 5 indexed citations
3.
Chen, Jonathan, et al.. (2022). Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL. Blood. 140(Supplement 1). 9896–9897. 1 indexed citations
4.
Chen, Jonathan, et al.. (2022). CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL. Clinical Lymphoma Myeloma & Leukemia. 22. S270–S271. 2 indexed citations
5.
Pleyer, Christopher, Kerry J. Laing, Mir A. Ali, et al.. (2022). BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL. Blood Advances. 6(6). 1732–1740. 18 indexed citations
6.
Sun, Clare, Christopher Pleyer, & Adrian Wiestner. (2021). COVID-19 vaccines for patients with haematological conditions. The Lancet Haematology. 8(5). e312–e314. 17 indexed citations
7.
Sun, Clare, Erika M. Gaglione, Chingiz Underbayev, et al.. (2021). Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL. Blood. 138(Supplement 1). 3724–3724. 4 indexed citations
8.
Pleyer, Christopher, Clare Sun, Inhye E. Ahn, et al.. (2020). Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors. Leukemia & lymphoma. 61(10). 2375–2382. 15 indexed citations
9.
Pleyer, Christopher, Mir A. Ali, Jeffrey I. Cohen, et al.. (2020). Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 137(2). 185–189. 84 indexed citations
10.
11.
Pleyer, Christopher, Adrian Wiestner, & Clare Sun. (2018). Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia. Leukemia & lymphoma. 59(12). 2792–2800. 28 indexed citations
12.
Pleyer, Christopher, Clare Sun, Xin Tian, et al.. (2018). Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib. Blood. 132(Supplement 1). 1874–1874. 6 indexed citations
13.
Molenaar, Remco J., Christopher Pleyer, Tomas Radivoyevitch, et al.. (2017). Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. Leukemia. 32(4). 952–959. 20 indexed citations
14.
Pleyer, Christopher, et al.. (2016). Phrenic nerve paralysis induced by brachial plexus block. Cleveland Clinic Journal of Medicine. 83(4). 250–251.
15.
Pleyer, Christopher, William Shomali, Paul Elson, et al.. (2015). Impact of Red Blood Cell and Platelet Transfusions in Acute Myeloid Leukemia (AML) Patients Undergoing Remission Induction Chemotherapy. Blood. 126(23). 2127–2127. 1 indexed citations
16.
Pleyer, Christopher, Jan Flesche, & Fahad Saeed. (2015). Lysozyme amyloidosis – a case report and review of the literature. PubMed. 3. 42–45. 32 indexed citations
17.
Pleyer, Christopher, Surbhi Sidana, Tomas Radivoyevitch, et al.. (2015). Radioactive Iodine Treatment of Thyroid Cancer and Risk of Myelodysplastic Syndromes. Blood. 126(23). 612–612. 1 indexed citations
18.
Pleyer, Christopher, H Bittner, G. Richard Locke, et al.. (2014). Overdiagnosis of gastro‐esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterology & Motility. 26(8). 1163–1171. 38 indexed citations
19.
Pleyer, Christopher, et al.. (2013). The role of young people in global health governance: an interview-based observational study. The Lancet. 382. 12–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjolein L. Donker Breakdown of academic impact, for papers by Benedetto Neri Breakdown of academic impact, for papers by L. S. Zubarovskaya Breakdown of academic impact, for papers by Cristina Estany Breakdown of academic impact, for papers by Juan S. Lasa Breakdown of academic impact, for papers by Sara Miqueleiz Breakdown of academic impact, for papers by Yasutaka Aoyama Breakdown of academic impact, for papers by E. L. Egan Breakdown of academic impact, for papers by Young Bae Choi Breakdown of academic impact, for papers by Connor Prosty
Rankless by CCL
2026